SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 16th, 2020 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”) dated as of December 10, 2020, by and between Propanc Biopharma Inc., a Delaware corporation, with headquarters located at 302, 6 Bulter Street, Camberwell, VIC 3124, Australia (the “Company”), and GW Holdings Group, LLC, a New York Limited Liability Company, with its address at 137 Montague Street, Suite 291, Brooklyn, NY 11201 (the “Buyer”).
